Van Cutsem E, Danielewicz I, Saunders MP, Pfeiffer P, et al. First-line trifluridine/tipiracil + bevacizumab in patients with unresectable metastatic colorectal cancer: final survival analysis in the TASCO1 study. Br J Cancer 2022 Apr 19. pii: 10.1038/s41416-022-01737.
PMID: 35440667